Corbus Pharmaceu (CRBP) Total Assets by Year
Corbus Pharmaceu closed fiscal year 2025 with $168.2M in total assets, $20.7M in total liabilities and $147.5M in shareholder equity. This represents an increase of 7.9% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Corbus Pharmaceu has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CRBP Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $168.2M+7.9% | $155.9M+451.4% | $28.3M-57.4% | $66.3M-38.4% | $107.7M+5.3% | $102.3M+108.2% | $49.1M+4.6% | $47.0M-29.8% | $67.0M+274.4% | $17.9M+38.9% | $12.9M+95.1% | $6.6M+2060.5% | $306K |
| Total Liabilities | $20.7M+53.8% | $13.5M-61.8% | $35.2M+5.6% | $33.3M-13.7% | $38.6M-32.3% | $57.0M+32.7% | $43.0M+120.8% | $19.5M+111.7% | $9.2M+2.5% | $9.0M+130.5% | $3.9M+427.1% | $738K-64.7% | $2.1M |
| Total Equity | $147.5M+3.6% | $142.4M+2162.7% | -$6.9M-120.9% | $33.0M-52.3% | $69.1M+52.6% | $45.3M+635.3% | $6.2M-77.6% | $27.5M-52.4% | $57.8M+547.9% | $8.9M-0.7% | $9.0M+53.3% | $5.9M+428.8% | -$1.8M |
CRBP Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $127.0M+1.5% | $144.5M+3.3% | $168.2M+7.9% | $109.5M-33.3% | $125.1M-17.7% | $139.9M+11.3% | $155.9M+451.4% | $164.2M+352.5% | $152.0M+247.6% | $125.7M+143.5% | $28.3M-57.4% | $36.3M-50.9% |
| Total Liabilities | $24.7M+75.6% | $18.1M+41.4% | $20.7M+53.8% | $17.4M+27.0% | $14.1M-46.7% | $12.8M-55.4% | $13.5M-61.8% | $13.7M-62.0% | $26.4M-22.7% | $28.8M-18.2% | $35.2M+5.6% | $36.0M+12.8% |
| Total Equity | $102.2M-7.9% | $126.3M-0.6% | $147.5M+3.6% | $92.1M-38.8% | $111.0M-11.6% | $127.1M+31.1% | $142.4M+2162.7% | $150.5M+48136.5% | $125.5M+1218.6% | $97.0M+489.1% | -$6.9M-120.9% | $312K-99.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Corbus Pharmaceu financials
Frequently Asked Questions
What was Corbus Pharmaceu's total assets in fiscal year 2025?
Corbus Pharmaceu closed fiscal year 2025 with $168.2M in total assets, $20.7M in total liabilities and $147.5M in shareholder equity.
How fast is Corbus Pharmaceu's total assets growing?
Corbus Pharmaceu (CRBP) total assets rose by 7.9% year over year, from $155.9M to $168.2M in fiscal year 2025.
How has Corbus Pharmaceu's total assets changed over the years?
Across the 13 fiscal years this page covers, Corbus Pharmaceu (CRBP) total assets went from $306K in fiscal year 2013 to $168.2M in fiscal year 2025.
What was Corbus Pharmaceu's total assets in the most recent quarter?
Corbus Pharmaceu (CRBP) reported $127.0M in total assets in Q2 2026. This represents an increase of 1.5% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Corbus Pharmaceu (CRBP) reported on that line in every period on record.